Chewy Focuses on Pet Health and AI for Future Growth

The company is targeting a net increase of 150,000 to 250,000 active customers and is projecting long-term revenue growth in the high-single to low-double-digit range. Chewy leverages its Autoship, mobile engagement, and artificial intelligence initiatives to enhance customer retention and spending, primarily through self-funded investments. Health acquisitions are prioritized for reinvestment, although international expansion remains a secondary focus.

At a Goldman Sachs conference, CEO Sumit Singh emphasized Chewy's commitment to U.S. health services and expanding customer spending. He noted that investments in supply chain and technical infrastructure, along with increased Autoship adoption, have solidified the company’s foundation for reinvestment. Singh identified the pet health market as a $50 billion opportunity, with an estimated $12 billion to $15 billion in products, including medications, prescription diets, supplements, and flea-and-tick treatments.

Since entering the health category in 2018, Chewy has become the largest pet pharmacy in the U.S., capturing approximately $0.70 of every dollar spent online in the pet medications space. In the previous six years, the company added around $9 billion in incremental revenue, with about $4 billion of that attributed to Chewy Health. However, Singh acknowledged that consumer interest in discretionary pet categories has decreased, particularly following increased market pressures observed in March and April, which led to an adjustment in the company's forecasts.